- Home
- CDLR vs AZTA Comparison
CDLR vs AZTA Comparison
Compare CDLR & AZTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CDLR
- AZTA
- Stock Information
- Founded
- CDLR 2008
- AZTA 1978
- Country
- CDLR Denmark
- AZTA United States
- Employees
- CDLR N/A
- AZTA N/A
- Industry
- CDLR
- AZTA Industrial Machinery/Components
- Sector
- CDLR
- AZTA Technology
- Exchange
- CDLR Nasdaq
- AZTA Nasdaq
- Market Cap
- CDLR 1.9B
- AZTA 1.8B
- IPO Year
- CDLR N/A
- AZTA 1995
- Fundamental
- Price
- CDLR $20.42
- AZTA $33.61
- Analyst Decision
- CDLR
- AZTA Buy
- Analyst Count
- CDLR 0
- AZTA 3
- Target Price
- CDLR N/A
- AZTA $45.00
- AVG Volume (30 Days)
- CDLR 91.8K
- AZTA 1.0M
- Earning Date
- CDLR 08-26-2025
- AZTA 08-05-2025
- Dividend Yield
- CDLR N/A
- AZTA N/A
- EPS Growth
- CDLR N/A
- AZTA N/A
- EPS
- CDLR 0.31
- AZTA N/A
- Revenue
- CDLR $319,011,025.00
- AZTA $669,171,000.00
- Revenue This Year
- CDLR $106.55
- AZTA N/A
- Revenue Next Year
- CDLR $92.34
- AZTA $4.89
- P/E Ratio
- CDLR $18.80
- AZTA N/A
- Revenue Growth
- CDLR 171.33
- AZTA 8.56
- 52 Week Low
- CDLR $17.37
- AZTA $23.91
- 52 Week High
- CDLR $28.75
- AZTA $63.58
- Technical
- Relative Strength Index (RSI)
- CDLR 49.76
- AZTA 63.57
- Support Level
- CDLR $19.64
- AZTA $31.41
- Resistance Level
- CDLR $20.27
- AZTA $34.95
- Average True Range (ATR)
- CDLR 0.44
- AZTA 1.49
- MACD
- CDLR -0.08
- AZTA 0.24
- Stochastic Oscillator
- CDLR 49.87
- AZTA 79.74
About CDLR Cadeler AS
Cadeler AS is an offshore wind farm vessel contractor. It is engaged in offshore wind farm construction, maintenance, and decommissioning and provides marine and engineering operations to the wind industry, focusing on safety and the environment. The company operates six offshore jack-up wind farm installation vessels. In addition to wind farm installation, these vessels can perform maintenance, construction, decommissioning, and other tasks within the offshore industry.
About AZTA Azenta Inc.
Azenta Inc is a provider of life sciences solutions, enabling impactful breakthroughs and therapies to market faster. It provides a full suite of reliable cold-chain sample management solutions and genomic services across areas such as drug development, clinical research and advanced cell therapies for the industry's top pharmaceutical, biotech, academic and healthcare institutions globally. The company has two reportable segments that are Life Sciences Products and Life Sciences Services. It generates a substantial part of its revenue from its Life Sciences Services segment.